APA (7th ed.) Citation

Li, Z., Zhao, Z., Liu, P., Zheng, Q., & Liu, C. (2021). Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet (扶正化瘀片) and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial. Chinese journal of integrative medicine, 27(7), 509-513. https://doi.org/10.1007/s11655-020-3257-6

Chicago Style (17th ed.) Citation

Li, Zheng-xin, Zhi-min Zhao, Ping Liu, Qing-shan Zheng, and Cheng-hai Liu. "Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet (扶正化瘀片) and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial." Chinese Journal of Integrative Medicine 27, no. 7 (2021): 509-513. https://doi.org/10.1007/s11655-020-3257-6.

MLA (9th ed.) Citation

Li, Zheng-xin, et al. "Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet (扶正化瘀片) and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial." Chinese Journal of Integrative Medicine, vol. 27, no. 7, 2021, pp. 509-513, https://doi.org/10.1007/s11655-020-3257-6.